The protease medicines company

Our programs:

The protease advantage
CB 4332 – SQ Enhanced Complement Factor I

Latest news

Sep 15, 2021

Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital

Sep 09, 2021

Catalyst Biosciences Announces Oral and Poster Presentations at the International Conference on Complement Therapeutics

Sep 08, 2021

Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors

X